Cholesterol biosynthetic pathway enzyme

"Cholesterol biosynthetic pathway enzyme" is not a single molecular entity but refers to any of several enzymes involved in the multi-step process that converts acetyl-CoA into cholesterol. This pathway includes numerous well-characterized enzymes such as HMG-CoA reductase, squalene synthase, squalene monooxygenase, lanosterol synthase, sterol 14α-demethylase, and others. Each plays a distinct role at different stages of cholesterol production. These enzymes are essential for cell membrane structure and serve as precursors for steroid hormones and bile acids[2][3]. Inhibitors targeting specific steps—such as statins acting on HMG-CoA reductase or experimental agents targeting lanosterol synthase—are used therapeutically to lower blood cholesterol levels[1]. However, "Cholesterol biosynthetic pathway enzyme" is too broad to be considered an individual therapeutic target; it should be replaced with the name of a specific enzyme within this metabolic route. There is something wrong with this target designation because it does not refer to one unique protein or gene product but rather an entire class/family comprising many distinct targets. For structured data purposes—and especially drug discovery—it is necessary to specify which exact step/enzyme in the cholesterol biosynthesis cascade is meant[1][2].

Other names

Cholesterol biosynthetic enzymeEnzyme of cholesterol synthesisCholesterol pathway enzyme